1989PubMedRequires access

[Neurotransmitters and neurologic disorders].

Ichiro Kanazawa

Open publisher page 0 citations

Abstract

Neurotransmitters should fulfil the following main three criteria; 1) they should be localized in synaptic terminals, 2) they should have certain actions on neurons, 3) they should be released from the terminals after nerve stimulation. In addition to the above three, recent studies have revealed that neurotransmitters should have their own receptors. Moreover, recent immunohistochemical studies have revealed certain neurons to have two or more neurotransmitter candidates; one classic and the other non-classic neurotransmitter candidate. These progresses in the field of neurotransmitter science were briefly reviewed. As an extension of the basic studies mentioned above, clinical studies of measurements of neurotransmitter markers in brains of neurodegenerative disorders are now actively performed. Based on my own studies in the same line, it is possible to summarize the fundamental patterns of neurotransmitter alterations in neurodegenerative disorders as follows: 1) they decrease as a result of degeneration of neuron groups (the most popular pattern); 2) they decrease in spite of the morphologically normal appearance of neurons ("biochemical non-functioning"); 3) they increase in the projecting regions of certain neurons which escaped degeneration. This may be a result of simple condensation of normal nerve terminals or real increase based on the compensatory mechanisms.

About this research paper

What this paper is about

Neurotransmitters should fulfil the following main three criteria; 1) they should be localized in synaptic terminals, 2) they should have certain actions on neurons, 3) they should be released from the terminals after nerve stimulation. In addition to the above three, recent studies have revealed that neurotransmitters should have their own receptors. Moreover, recent immunohistochemical studies have revealed certain neurons to have two or more neurotransmitter candidates; one classic and the other non-classic neurotransmitter candidate. These progresses in the field of neurotransmitter science were briefly reviewed. As an extension of the basic studies mentioned above, clinical studies of measurements of neurotransmitter markers in brains of neurodegenerative disorders are now actively performed. Based on my own studies in the same line, it is possible to summarize the fundamental patterns of neurotransmitter alterations in neurodegenerative disorders as follows: 1) they decrease as a result of degeneration of neuron groups (the most popular pattern); 2) they decrease in spite of the morphologically normal appearance of neurons ("biochemical non-functioning"); 3) they increase in the projecting regions of certain neurons which escaped degeneration. This may be a result of simple condensation of normal nerve terminals or real increase based on the compensatory mechanisms.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Neurotransmitters should fulfil the following main three criteria; 1) they should be localized in synaptic terminals, 2) they should have certain actions on neurons, 3) they should be released from the terminals after nerve stimulation. In addition to the above three, recent studies have revealed that neurotransmitters should have their own receptors. Moreover, recent immunohistochemical studies have revealed certain neurons to have two or more neurotransmitter candidates; one classic and the other non-classic neurotransmitter candidate. These progresses in the field of neurotransmitter science were briefly reviewed. As an extension of the basic studies mentioned above, clinical studies of measurements of neurotransmitter markers in brains of neurodegenerative disorders are now actively performed. Based on my own studies in the same line, it is possible to summarize the fundamental patterns of neurotransmitter alterations in neurodegenerative disorders as follows: 1) they decrease as a result of degeneration of neuron groups (the most popular pattern); 2) they decrease in spite of the morphologically normal appearance of neurons ("biochemical non-functioning"); 3) they increase in the projecting regions of certain neurons which escaped degeneration. This may be a result of simple condensation of normal nerve terminals or real increase based on the compensatory mechanisms.

Key concepts: Neurotransmitter, Neuroscience, Neurotransmitter receptor, Neurotransmission, Neurotransmitter Agents, Degeneration (medical), Neurotransmitter systems, Neuron

Related papers

Back to paper searchBrowse research topicsOriginal source
[Neurotransmitters and neurologic disorders]. — Research Paper | ScholarLens